Recent studies suggest an involvement of CD26/DP IV-activity in the pathogenesis of MS, including T-cell activation, cytokine production and lymphocyte invasion into CNS tissues, through the proteolytic processing of target chemokines [22,33,61]. The gene discussed is DPP4; the disease is myeloid sarcoma.